Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour

Citation

Grimpen, F, Yip, D, McArthur, G et al 2005, 'Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour', Lancet Oncology, The, vol. 6, pp. 724-727.

Year

2005

ANU Authors

Field of Research

  • Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)

Updated:  03 February 2023 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers